Back to results

University of Ontario Institute of Technology

Proportional-integral control in the evaluation of glucose homeostasis and Type 2 Diabetes

Abstract

dc:description.abstract

Mathematical modelling of blood sugar dynamics has been explored since the early 1960s. For most of these models, measurements of hormones such as insulin and glucagon are required to find parameter values that yield plausible glucose behaviour. These hormone measurements require repeated blood tests and limit the feasibility of applying the model to “real world” medical applications such as disease diagnosis. We apply a proportional-integral control model to human glucose homeostasis. The model can be fit using glucose data obtained exclusively from a continuous glucose monitor, and measurements of hormone concentrations do not need to be taken. The resulting parameters from model tuning can be used as an evaluation of the effectiveness of an individual’s blood glucose homeostasis and as a biomarker of diabetic status. This research has the potential to be a diagnostic or intervention tool in type 2 diabetes and may aid in the early prediction of prediabetes.

Degree

thesis:*
Name thesis:degree_name
Master of Science (MSc)
Discipline thesis:degree_discipline
Modelling and Computational Science
Grantor dc:publisher
University of Ontario Institute of Technology
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kaufman, Jaycee
Advisor dc:contributor.advisor
  • van Veen, Lennaert

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/10155/1480
OAI identifier oai:identifier
oai:ontariotechu.scholaris.ca:10155/1480

Chain of custody

source
Harvested from
Ontario Institute of Technology
Base URL
ontariotechu.scholaris.ca/server/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Kaufman, Jaycee. Proportional-integral control in the evaluation of glucose homeostasis and Type 2 Diabetes. University of Ontario Institute of Technology, 2022. https://hdl.handle.net/10155/1480